Milestone Pharmaceuticals Inc.
MIST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001408443
No open-market purchases or sales by Milestone Pharmaceuticals Inc. insiders were filed in the last 90 days; 78 institutions reported holding it in 13F filings for Q2 2026, worth $66.4M in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Milestone Pharmaceuticals Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Of which not filed for Q2 2026 | Q2 2026 | Change |
|---|---|---|---|---|
| Holders | 87 | 2 | 78 | −7 |
| Shares | 39.5M | 30.0K | 49.6M | +10.1M (+25.5%) |
| Value | $47.2M | $35.7K | $66.4M | +$19.2M (+40.7%) |
2 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (6)
Institutions that held Milestone Pharmaceuticals Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Kalehua Capital Management LLC | 1,269,237 | $1.70M | 0.98% |
| Cascades Capital Asset Management, LLC | 83,610 | $112.0K | 0.04% |
| Two Sigma Securities, LLC | 16,745 | $22.4K | 0.00% |
| Winton Group Ltd | 14,300 | $19.2K | 0.00% |
| Virtu Financial LLC | 11,613 | $16.0K | 0.00% |
| SRS Capital Advisors, Inc. | 3,053 | $4.09K | 0.00% |
Sold out (13)
Institutions that held Milestone Pharmaceuticals Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Goldman Sachs Group Inc | 2,000,025 | $2.38M |
| Renaissance Technologies LLC | 129,705 | $154.3K |
| HRT Financial LP | 62,256 | $74.0K |
| Invesco Ltd. | 41,356 | $49.2K |
| Northern Trust Corp | 38,779 | $46.1K |
| Gsa Capital Partners LLP | 26,893 | $32.0K |
| Acadian Asset Management LLC | 20,468 | $24.0K |
| SJS Investment Consulting Inc. | 15,000 | $17.9K |
| IMC-Chicago, LLC | 10,943 | $13.0K |
| Bayesian Capital Management, LP | 10,015 | $11.9K |
| Ancora Advisors, LLC | 10,000 | $11.9K |
| Key Capital Management, INC | 212 | $252 |
| Russell Investments Group, Ltd. | 125 | $149 |
Not filed for Q2 2026 yet (2)
Institutions that held Milestone Pharmaceuticals Inc. at the end of Q1 2026 and haven't filed a 13F for Q2 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Journey Strategic Wealth LLC | 20,000 | $23.8K |
| CWM, LLC | 10,000 | $11.9K |